InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RFP | Ann:Revised FY19 profit forecast (Price Sensitive) | 25/03/19 | 0 | 40 | |||
|
|||||||
RFP | Ann:Distribution Quarter ending 31 March 2019 | 01/03/19 | 0 | 252 | |||
|
|||||||
RFP | Ann:Appendix 3 (Price Sensitive) | 27/02/19 | 0 | 297 | |||
|
|||||||
RFP | Ann:RFP HY19 Financial Statements (Price Sensitive) | 27/02/19 | 0 | 442 | |||
|
|||||||
RFP | Ann:RFP HY19 Results Presentation (Price Sensitive) | 27/02/19 | 0 | 319 | |||
|
|||||||
RFP | Ann:Poultry shed upgrade funding (Price Sensitive) | 21/02/19 | 0 | 330 | |||
|
|||||||
RFP | Ann:Operational and financial update (Price Sensitive) | 06/02/19 | 0 | 335 | |||
|
|||||||
RFP | Ann:Updated policies | 31/01/19 | 0 | 300 | |||
|
See All Discussions